Angiogenesis: New insights and therapeutic potential

Anatomical Record

Volumn 261, Issue 3, 2000, Pages 126-135

  Tomanek, Robert J ^a   Schatteman, Gina C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Angiogenesis; Diabetes; Growth factors; Stem cells; Stroke; Therapeutics; Tumors

Indexed keywords

ANGIOGENIC FACTOR; GROWTH FACTOR;

ANGIOGENESIS; BLOOD VESSEL; CELL INTERACTION; DIABETES MELLITUS; ISCHEMIC HEART DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STROKE; TUMOR GROWTH;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANIMALS; HUMANS; MYOCARDIAL ISCHEMIA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0034659306     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0185(20000615)261:3<126::AID-AR7>3.0.CO;2-4     Document Type: Review

References (75)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R. et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
2. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM. 1998. Tie 2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnatal neovascularization. Circ Res 83:233240.
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, et al. 1999a. Bone marrow origin of endothelial cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
4. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. 1999b. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-3972.
5. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. 1994. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc Res 28:1176-1179.
6. Bischoff J. 1995. Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol 5:69-74.
7. Brooks PC, RAF Clark, and DA Cheresh. 1994. Requirement of vascular integrin av3 for angiogenesis. Science 264:569571.
8. Brooks PC. 1996. Role of integrins in angiogenesis. EurJ Cancer 32A:2423-2429.
9. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L., Gertsenstein M, Fahrig M, Vandenhoeck A, Kendraprased H, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth factor allele. Nature 380:435-439.
10. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725-732.
11. Deindl E, Fernandez B, Höfer IE, van Royen N, Scholz D, Schaper W. 2000. Arteriogenesis, collateral blood vessels, and their development. In: Angiogenesis in health and disease. Basic mechanisms and clinical applications. New York: Marcel Decker Inc., p 75-88.
12. Drake CJ, Hungerford JE, Little CD. 1998. Morphogenesis of the first blood vessels. Ann NY Acad Sei 857:155-179.
13. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-1909.
14. Dvorak FH, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. 1987. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57:673-686.
15. Eichmann A, Corbel C, Nataf V, Vaigot P, Breant C, et al. 1997. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sei USA 94: 5141-5146.
16. Fan T-P, Jaggar R, Bicknell R. 1995. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Tips 16:57-66.
17. Ferrara N, Gerber HP. 1999. The vascular endothelial growth factor family. In: Ware JA, Simons M, editors. Angiogenesis and cardiovascular disease. New York: Oxford University Press, p 101127.
18. Ferrara N. 2000. The role of vascular endothelial growth factor in angiogenesis. In: Angiogenesis in health and disease. Basic mechanisms and clinical applications. New York: Marcel Decker Inc., p 47-73.
19. Folkman J, Merler E, Abernathy C, Williams G. 1971. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133:275-288.
20. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
21. Gerber HP, Condorelli F, Park J, Ferrara N. 1997. Differential transcription regulation of the two VEGF receptor genes. Fit-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272:23659-23667.
22. Hanahan D, Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
23. Henry TD. 1999. Therapuetic angiogenesis. BMJ 318:1536-1539.
24. Hirschi KK, D'Amore PA. 1996. Pericytes in the microvasculature. Cardiovasc Res 32:687-698.
25. Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D'Amore PA. 1999. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth Factor-BB and heterotypic cell contact. Circ Res 84:298-305.
26. Hudlicka O, TylerKR. 1986. Angiogenesis. The growth of the vascular system. London: Academic Press, p 3.
27. Hudlicka O, Brown MD. 2000. Modulators of angiogenesis. Hemodynamic factors. In: Angiogenesis in health and disease: basic mechanisms and clinical applications. New York: Marcel Decker Inc., p 215-244.
28. Hueper VC, Russell MA. 1932. "Capillarylike formations" in tissue cultures of leukocytes. Arch Exp Zellforsch 12:407-424.
29. Ingber DE. 1990. Fibronectin controls endothelial cell growth by modulating cell shape. Proc Natl Acad Sei USA 87:35793583.
30. Isner JM. Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T. 2000. Therapeutic angiogenesis in peripheral limb ischemia. In: Angiogenesis in health and disease: basic mechanisms and clinical applications. New York: Marcel Decker Inc., p 321-342.
31. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 15:1751.
32. Kanno S, Oda N, Abe M, Saito S, Hon K, Handa Y, Tabayashi K, Sato Y. 1999. Establishment of a simple and practical procedure applicable to therapeutic angiogenesis. Circulation 99:2682-2687.
33. Kashiwagi Y, Haneda T, Osaki J, Miyata S, Kikuchi K. 1998. Mechanical stretch activates a pathway linked to mevalonate metabolism in cultured neonatal rat heart cells. Hypertens Res 21:109-119.
34. Klagsbrun M. 1989. The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1:207-235.
35. Laham RJ, Simons M. 2000. Growth factor therapy in ischémie heart disease. In: Angiogenesis in health and disease: basic mechanisms and clinical applications. New York: Marcel Decker Inc., p 451464.
36. Levy AP, Levy NS, Goldberg MA. 1996. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271:2746-2753.
37. Li J, Hampton T, Morgan JP, Simons M. 1997. Stretch-induced VEGF expression in the heart. J Clin Invest 100:18-24.
38. Mackenzie JR, Hackett M, Topuzlu C, Tibbs DJ. 1968. Origin of arterial prosthesis lining from circulating blood cells. Arch Surg 97:879-885.
39. Madri JA, Pratt BM, Tucker AM. 1988. Phenotypic modulation of endothelial cells by transforming growth factor-β depends on the composition and organization of the extracellular matrix. J Cell Biol 106:1375-1384.
40. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand S, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin 2, a natural antagonist for Tie 2 that disrupts HI vivo angiogenesis. Science 277:55-60.
41. McNamara DA, Harmey JH, Walsh TN, Redmond HP, Bouchier-Hayes DJ. 1998. Significance of angiogenesis in cancer therapy. Br J Surg 85:1044-1055.
42. Nicosia RF, Villaschi S. 1999. Autoregulation of angiogenesis by cells of the vascular wall. Int Rev Cytol 185:1-43.
43. Norrby K. 1997. Angiogenesis: new aspects relating to its initiation and control. APMIS 105:417-437.
44. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U. 1996. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sei USA 93:25762581.
45. Onuki Y, Kouchi Y, Yoshida H, Wu MH, Shi Q, Wechezak AR, Coan D, Sauvage LR. 1998. Early flow surface endothelialization before microvessel ingrowth in accelerated graft healing, with BrdU identification of cellular proliferation. Ann Vase Surg 12:207-215.
46. Ortega N, F-E L'Faqihi, J Plouet. 1998. Control of vascular endothelial growth factor activity by the extracellular matrix. Biol Cell 90:381-390.
47. Pepper MS. 1997a. Manipulating angiogenesis: from basic science to the bedside. Arterialsclerosis Thromb Vase Biol 17:605-619.
48. Pepper MS. 1997b. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Fact Rev 8:21-43.
49. Reidy MA, Lindner V. 1991. Basic FGF and growth of arterial cells. Ann NY Acad Sei 638:290-9.
50. Rivard A, Isner JM. 1998. Angiogenesis and vasculogenesis in treatment of cardiovascular disease. Mol Med 4:420-440.
51. Rongish BJ, Hinchman G, Doty MK, Baldwin HS, Tomanek RJ. 1996. Relationship of the extracellular matrix to coronary neovascularization during development. J Mol Cell Cardiol 28:2203-2215.
52. Schaper W, Ito W. 1996. Molecular mechanisms of coronary collateral vessel growth. Circ Res 79:911-919.
53. Schaper W, Vandesteene R. 1967. The rate of growth of interarterial anastomoses in chronic coronary artery occlusion. Life Sei 6:1673-80.
54. Schatteman GC, Motley ST, Effmann EL, Bowen-Pope DF. 1995. Platelet-derived growth factor receptor alpha subunit deleted Patch mouse exhibits severe cardiovascular dysmorphogenesis. Teratology 51:351-66.
55. Seko Y, Seko Y, Takahashi N, Shibuya M, Yazaka Y. 1999. Pulsatile stretch stimu-lates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun 254:462-465.
56. Shah N, Groves AK, Anderson DJ. 1996. Alternative neural crest fates are instructively promoted by TGFβ superfamily members. Cell 85:331-343.
57. Sheibani N, Frazier WA. 1999. Thrombospondin-1, PECAM-1, and regulation of angiogenesis. Histol Histopathol 14: 285-294.
58. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond VP. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367.
59. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. 1984. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223:1296-1299.
60. Spangrude GJ, Heimfejd S, Weissman IL. 198?. Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62.
61. Stone J, Chan-Ling T, Peer J, Itin A, Gnessin H, Keshet E. 1996. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthal Vis Sei 37:290-299.
62. Streuli C. 1999. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 11:634-640.
63. Stump MM, Jordan JL Jr., DeBakey ME, Halpert B. 1963. Endothelium grown from circulating blood on isolated intravascular Dacron hub. Am J Pathol 43: 361-367.
64. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471.
65. Takahashi T, Kalka C, Masuda H, Chen D, Silver M. et al. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
66. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-2514.
67. Tomanek RJ. 1999. Angiogenesis in the nonischemic myocardium. In: Ware JA, Simons M, editors. Angiogenesis and cardiovascular disease. New York: Oxford University Press, p 1999-212.
68. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz, Correa R, Klingbeil C, Epstein SE. 1994. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266:H1588H1595.
69. Valaitis J, McGrew EA, McGrath RG, Roberts SS. 1968. Capillary cell clusters in peripheral blood of postoperative cancer and noncancer patients. Acta Cytol 12: 439.
70. Van Groningen JP, Wenink ACG, Testers LHM. 1991. Myocardial capillaries: increase in number by splitting of existing vessels. Acta Embryol 184:65-70.
71. Varner, JA. 1997. The role of vascular cell integrins av3 and av3 in angiogenesis. In: Goldberg ID, Rosen EM, editors. Regulation of angiogenesis. Basel: Birkhauser Verlag, p 361-390.
72. Wynendaele W, van Oosterom AT, Pawinski A, de Bruijin EA, Maes RA. 1998. Angiogenesis: possibilities for therapeutic interventions. Pharm World Sei 20: 225-235.
73. Yue X, Tomanek RJ. 1999. Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts. DevDyn 216:28-36.
74. Zheng W, Brown MD, Brock TA, Bjercke RJ, Tomanek RJ. 1999. Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Cire Res 85:192-198.
75. Ziegler BL, Valtieri M, Porada GA, De Maria R, Muller R. et al. 1999. KDR receptor: a key marker defining hematopoietic stem cells. Science 285:1553-1558.